SciELO - Scientific Electronic Library Online

vol.76 issue3 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links

  • On index processCited by Google
  • On index processSimilars in Google


Onderstepoort Journal of Veterinary Research

On-line version ISSN 2219-0635
Print version ISSN 0030-2465

Onderstepoort j. vet. res. vol.76 n.3 Pretoria  2009




Study on the efficacy and safety of different antigens and oil formulations of infectious coryza vaccines containing an NAD-independent strain of Avibacterium paragallinarum



B. DunguI; B. BrettI; R. MacdonaldI; S. DevilleII; L. DupuisII; J. TheronIII; R.R. BraggIV

IOnderstepoort Biological Products, Private Bag X07, Onderstepoort, 0110 South Africa
IISEPPIC, Tour Kupka C-7, Bld Franck Kupka, 92039 Paris, France
IIIDepartment of Microbiology and Plant Pathology, University of Pretoria, Pretoria, 0002 South Africa
IVUniversity of the Free State, P.O. Box 339, Bloemfontein, 9300 South Africa




The present study was designed to assess and compare three different formulations of the new Onderstepoort infectious coryza (IC) quadrivalent vaccine, which contain an NAD-independent strain of Avibacterium paragallinarum (previously known as Haemophilus paragallinarum), and a commercial IC vaccine, not containing an NAD-independent strain, for their safety and ability to protect chickens of varying ages against virulent challenges with four different serovars of A. paragallinarum, including the NAD-independent strain of the C-3 serovar.
Four groups of 140 chickens each were vaccinated at the age of 17 weeks and revaccinated at the age of 19 weeks with each of the four vaccine formulations. A similar sized group of non-vaccinated chickens was used as control. Two rounds of challenge were conducted: a group of chicken in each vaccination group was challenged between 31 and 35 weeks of age, while another group was challenged between 51 and 55 weeks of age. The "in-contact" challenge model was used in this experiment. For each vaccination group, the four challenge strains representing four local serovars were used in each challenge round. The efficacy of the vaccines was compared based on overall protection levels obtained and the duration of protection. The safety of the different vaccines was determined by the severity of post-vaccination reactions.
The need for the incorporation of the NAD-independent strain in the vaccine was evidenced by the low protection level against NAD-independent challenge recorded in the group of birds vaccinated with the commercial vaccine. The results obtained confirmed not only the variation in virulence of different South African serovars, with serovar C-3 being the most virulent and serovar B having almost no virulence but also the age related increase in susceptibility. The importance of a suitable formulation of the vaccine is discussed.

Keywords: Avibacterium paragallinarum, C-3 serovar, chickens, coryza vaccine, NAD-independent strain



“Full text available only in PDF format”




AUCOUTURIER J., DUPUIS L. & GANNE V. 2001. Adjuvants designed for veterinary and human vaccines. Vaccine, 19: 2666-2672.         [ Links ]

BLACKALL, P.J. 1999. Infectious coryza: overview of the disease and new diagnostic options. Clinical Microbiological Review, 12:627-32.         [ Links ]

BLACKALL, P.J., EAVES, L.E. & ROGERS D.G. 1990. Proposal of a new serovar and altered nomenclature for Haemophilus paragallinarum in the Kume hemagglutinin scheme. Journal of Clinical Microbiology, 28:1185-1187.         [ Links ]

BLACKALL, P.J., CHRISTENSEN, H., BECKENHAM, T., BLACKALL, L.L. & BISGAARD, M. 2005. Reclassification of Pasteurella gallinarum, Haemophilus paragallinarum, Pasteurella avium and Pasteurella volantium as Avibacterium gallinarum gen. nov. comb. nov., Avibacterium paragallinarum comb. nov., Avibacterium avium comb. nov. and Avibacterium vol-antium comb. nov. International Journal of Systematic and Evolutionary Microbiology, 55:353-362.         [ Links ]

BRAGG, R.R. 2002a. Virulence of South African isolates of Haemophilus paragallinarum. Part 1: NAD-dependent field isolates. Onderstepoort Journal of Veterinary Research, 69: 163-169.         [ Links ]

BRAGG, R.R. 2002b. Virulence of South African isolates of Haemophilus paragallinarum. Part 2: Naturally occurring NAD-independent field isolates. Onderstepoort Journal of Veterinary Research, 69:171-175.         [ Links ]

BRAGG, R.R., COETZEE, L. & VERSCHOOR, J.A. 1993. Plasmid encoded NAD independence in some South African isolates of Haemophilus paragallinarum. Onderstepoort Journal of Veterinary Research, 60:147-152.         [ Links ]

BRAGG, R.R., COETZEE L. & VERSCHOOR, J.A. 1996. Changes in the incidences of the different serovars of Haemophilus paragallinarum in South Africa; a possible explanation of vaccination failures. Onderstepoort Journal of Veterinary Research, 63:217-226.         [ Links ]

BRAGG, R.R. 2004. Evidence of possible evasion of protective immunity by NAD-independent isolates of Haemophilus paragallinarum in poultry. Onderstepoort Journal of Veterinary Research, 71:53-58.         [ Links ]

BUYS, S.B. 1982. Die bereiding van bakterieë teen Haemophilus paragallinarum besmetting, geskik vir Suid-Afrikaanse omstandighede. M.Med.Vet. thesis, University of Pretoria.         [ Links ]

DROUAL, R., BICKFORD A.A., CHARLTON B.R., COOPER G.L. & CHANNING, S.E. 1990. Infectious coryza in meat chickens in the San Joaquin Valley of California. Avian Diseases, 34:1009-1016.         [ Links ]

DUPUIS, L., ASCARATEIL, S., AUCOUTURIER, J. & GANNE, V. 2006. SEPPIC vaccine adjuvants for poultry. Annals of the New York Academy of Science, 1081:202-205.         [ Links ]

HORNER, R.F., BISHOP, G.C., JARVIS, C.J. & COETZEE, T.H.T. 1995. NAD (V-factor)-independent and typical Haemophilus paragallinarum infecting commercial chickens: a five year field study. Avian Pathology, 24:453-463.         [ Links ]

JACOBS, A.A. & VAN DER WERF, J. 2000. Efficacy of a commercially available coryza vaccine against challenge with recent South African NAD-independent isolates of Haemophilus paragallinarum in chickens. Journal of the South African Veterinary Association, 71:109-110.         [ Links ]

JANSEN, T., HOFMANS, M.P.M., THEELEN, M.J.G., MANDERS, F. & SCHIJNS V.E.J.C. 2006. Structure- and oil type-based efficacy of emulsion adjuvants. Vaccine, 24:5400-5405.         [ Links ]

JANSEN, T., HOFMANS, M.P.M., THEELEN, M.J.G. & SCHIJNS, V.E.J.C. 2005. Structure-activity relations of water-in-oil vaccine formulations and induced antigen-specific antibody responses Vaccine, 23:1053-1060.         [ Links ]

KUME, K., SAWATA, A., NAKAI, T. & MATSUMOTO, ? 1983. Serological classification of Haemophilus paragallinarum with a hemagglutinin system. Journal of Clinical Microbiology, 17: 958-964.         [ Links ]

MIFLIN, J.K., HORNER, R.F., BLACKALL, P.J., CHEN, X., BISHOP, G.C., MORROW, C.J., YAMAGUCHI, T. &. IRITANI, Y. 1995. Phenotypic and molecular characterization of V-factor (NAD)-independent Haemophilus paragallinarum. Avian Diseases, 39:304-308.         [ Links ]

MOUAHID, M., BISGAARD, M., MORLEY, A.J., MUTTERS, R. & MANNHEIM, W. 1992. Occurrence of V-factor (NAD) independent strains of Haemophilus paragallinarum. Veterinary Microbiology, 31:363-368.         [ Links ]

PAGE, L.A. 1962. Haemophilus infections in chickens: I. Characteristics of 12 Haemophilus isolates recovered from diseased chickens. American Journal of Veterinary Research, 23:85-95.         [ Links ]

TAOLE, M., ALBERTYN, J., VAN HEERDEN, E. & BRAGG, R.R. 2002. Virulence of South African isolates of Haemophilus paragallinarum. Part 3: experimentally produced NAD-independent isolates. Onderstepoort Journal of Veterinary Research, 69:189-196.         [ Links ]

TERZOLO, H.R., SANDOVAL, V.E. & GONZALEZ PONDAL, F. 1997. Evaluation of inactivated infectious coryza vaccines in chickens challenged by serovar B strains of Haemophilus paragallinarum. Avian Pathology, 26:365-376.         [ Links ]

STONE, H.D.1988. Optimization of hydrophile-lipophile balance for improved efficacy of Newcastle disease and avian influenza oil-emulsion vaccines. Avian Diseases, 32:68-73.         [ Links ]



Accepted for publication 19 April 2009-Editor



* Author to whom correspondence is to be directed. Present address: GALVmed, Edinburgh EH26 OPZ Scotland, UK. E-mail:

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License